EPIX Pharmaceuticals, Inc.
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1988-01-01
- Employees
- 91
- Market Cap
- -
- Website
- http://www.epixpharma.com
Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease
- Conditions
- Alzheimer's Disease
- Interventions
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2009-07-30
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 236
- Registration Number
- NCT00693004
- Locations
- ๐บ๐ธ
Barrow Neurological Institute, Phoenix, Arizona, United States
๐บ๐ธMeridien Research, St. Petersburg, Florida, United States
๐บ๐ธTorrance Clinical Research, Torrance, California, United States
An Open-Label Study to Evaluate the Safety and Efficacy of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
- First Posted Date
- 2008-05-15
- Last Posted Date
- 2009-07-30
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT00677872
- Locations
- ๐บ๐ธ
Massachusetts General Hospital Pulmonary and Critical Care Unit, Boston, Massachusetts, United States
A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil
- First Posted Date
- 2008-05-06
- Last Posted Date
- 2009-07-30
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 420
- Registration Number
- NCT00672945
- Locations
- ๐บ๐ธ
Bradenton Research Center, Bradenton, Florida, United States
๐บ๐ธBerma Research Group, Plantation, Florida, United States
๐บ๐ธMaine Neurology, Scarborough, Maine, United States
A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder
- Conditions
- Major Depressive Disorder (MDD)
- Interventions
- Drug: PRX-00023Drug: Placebo for PRX-00023
- First Posted Date
- 2007-03-16
- Last Posted Date
- 2007-11-14
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 330
- Registration Number
- NCT00448292
- Locations
- ๐บ๐ธ
AVI Clinical Research, Torrance, California, United States
๐บ๐ธVince and Associates Clinical Research, Overland Park, Kansas, United States
๐บ๐ธUniversity of Texas - Southwestern Medical Center, Dallas, Texas, United States
Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept
- Conditions
- Alzheimer's Disease
- First Posted Date
- 2006-10-06
- Last Posted Date
- 2008-01-30
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT00384423
- Locations
- ๐บ๐ธ
Southwest CLinical Research, Rancho Mirage, California, United States
๐บ๐ธComprehensive NeuroScience, Inc, St. Petersburg, Florida, United States
๐บ๐ธAtlanta Center for Medical Research, Atlanta, Georgia, United States
Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
- Conditions
- Pulmonary HypertensionChronic Obstructive Pulmonary Disease
- First Posted Date
- 2006-06-28
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT00345774
- Locations
- ๐บ๐ธ
Pulmonary Consultants of North Idaho, Coeur d'Alene, Idaho, United States
๐บ๐ธCentral Medical Group, PA, Tamarac, Florida, United States
๐บ๐ธBuffalo Cardiology and Pulmonary Associates, P.C., Williamsville, New York, United States
A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)
- Conditions
- Anxiety Disorders
- First Posted Date
- 2005-11-03
- Last Posted Date
- 2008-04-03
- Lead Sponsor
- Epix Pharmaceuticals, Inc.
- Target Recruit Count
- 310
- Registration Number
- NCT00248183
- Locations
- ๐บ๐ธ
UT Southwestern Medical Center, Dallas, Texas, United States
๐บ๐ธVista Medical Research, Mesa, Arizona, United States
๐บ๐ธGulf Coast Clinical Research Center, Fort Myers, Florida, United States